Sian Bigora - 05 Aug 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Development Officer
Signature
/s/ Sian Bigora by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
05 Aug 2022
Net transactions value
$0
Form type
4
Filing time
09 Aug 2022, 16:25:08 UTC
Previous filing
05 Jul 2022
Next filing
03 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +7,601 +1.9% 403,019 05 Aug 2022 Direct F1
holding PCSA Common Stock 133,353 05 Aug 2022 By CorLyst, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of time-based restricted shares.